SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001664710-22-000015
Filing Date
2022-03-09
Accepted
2022-03-09 16:27:22
Documents
6
Effectiveness Date
2022-03-09

Document Format Files

Seq Description Document Type Size
1 S-8 keros-formsx82022.htm S-8 72933
2 EX-FILING FEES exhibit107.htm EX-FILING FEES 26633
3 EX-5.1 exhibit51-sx82022.htm EX-5.1 9935
4 EX-23.1 exhibit231-sx82022.htm EX-23.1 1978
5 cooleylogo.jpg GRAPHIC 102892
6 image_0.jpg GRAPHIC 72
  Complete submission text file 0001664710-22-000015.txt   253514
Mailing Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421 617-513-8774
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263394 | Film No.: 22725702
SIC: 2834 Pharmaceutical Preparations